Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Epub 2013 Mar 28
Smiles: CS(O)(=O)=O
Crystal structures of GSK2801 demonstrated a canonical acetyl-lysine competitive binding mode
The effect of adjuvant dimethylenastron
Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics
RK-33 - DDX3 inhibitor. CAS# 1070773-09-9 Catalog No.:M6511-2 Epub 2013 Mar 28DDX3 inhibitor, CAS No. 1070773 09 9, RK 33 binds to DDX3 and abrogates its activity. Inhibition of DDX3 by RK 33 caused G1 cell cycle arrest, induced apoptosis, and promoted radiation sensitization in DDX3 overexpressing cells. Overall, inhibition of DDX3 by RK 33 promotes tumor regression, thus providing a compelling argument to develop DDX3 inhibitors for lung cancer therapy. RK 33 radiosensitizes prostate cancer cells by blocking the RNA helicase
US$ 40.00
US$ 105.00
US$ 35.00
US$ 137.50
US$ 25.00
US$ 35.00
US$ 867.50
US$ 169.00
US$ 35.00